Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
74 Cards in this Set
- Front
- Back
Tricyclic for OCD
|
Clomipramine
|
|
Tricyclic for OCD
|
Clomipramine
|
|
besides methylphenidat what else can be used to treat adhd
|
detroamph, pemoline
|
|
besides methylphenidat what else can be used to treat adhd
|
detroamph, pemoline
|
|
what constitutes a mild leukopenia
|
3000 - 3500
|
|
what constitutes a mild leukopenia
|
3000 - 3500
|
|
what constitutes a mild leukopenia
|
3000 - 3500
|
|
what does one do if a patietn on cloxapine develops a mild leukopenia with or w/o sx
|
institute a minimum of twice weekly CBCs
|
|
what does one do if a patietn on cloxapine develops a mild leukopenia with or w/o sx
|
institute a minimum of twice weekly CBCs
|
|
what does one do if a patietn on cloxapine develops a mild leukopenia with or w/o sx
|
institute a minimum of twice weekly CBCs
|
|
when would a psychiatrist need to get daily CBCs with someone on clozapine
|
WBCs of 2000 - 3000 and stop the clozapine
|
|
when would a psychiatrist need to get daily CBCs with someone on clozapine
|
WBCs of 2000 - 3000 and stop the clozapine
|
|
with an uncomplicated agranulocytosis (below 2,000) of a patient on clozapine what does one do?
|
D/C clozapine, isolate patietn, and get a bone marrow sample.
|
|
wconstitutes mild to moderate Lithium tox?hat
|
serum levels up to 3
|
|
wconstitutes mild to moderate Lithium tox?hat
|
serum levels up to 3
|
|
what is the Tx for mild to moderate lithium toxicity (levels up to 3)
|
IV saline, Urine output monitoring and frequent lithium levels
|
|
what is the Tx for mild to moderate lithium toxicity (levels up to 3)
|
IV saline, Urine output monitoring and frequent lithium levels
|
|
when does a patient on lithium need to be dialyzed?
|
over 3
|
|
when does a patient on lithium need to be dialyzed?
|
over 3
|
|
MC side effect of ramelteon?
|
H/A
|
|
MC side effect of ramelteon?
|
H/A
|
|
LAAM?
|
opiod agonist that supresses opioid withdrawal because of QT prolongation
|
|
LAAM?
|
opiod agonist that supresses opioid withdrawal no longer used because of QTprolongation
|
|
what counteracts BZDs?
|
flumazenil
|
|
what counteracts BZDs?
|
flumazenil
|
|
what TCA really causes weight gain?
|
amitriptaline
|
|
what TCA really causes weight gain?
|
amitriptaline
|
|
what happens if your bipolar patient on lithium develops hypothyroidism?
|
synthroid
|
|
what happens if your bipolar patient on lithium develops hypothyroidism?
|
synthroid
|
|
is tegratol's aplastic anemia dose-related?
|
not dose related
|
|
is tegratol's aplastic anemia dose-related?
|
not dose related
|
|
is tegratol's aplastic anemia dose-related?
|
not dose related
|
|
if a patient comes in to the ER with acute dystonia related to AP meds what should the treatment consist of?
|
benztropine or benadryl IM
IM IM IM |
|
if a patient comes in to the ER with acute dystonia related to AP meds what should the treatment consist of?
|
benztropine or benadryl IM
IM IM IM |
|
big side effect of olanzapine
|
DM
|
|
big side effect of olanzapine
|
DM
|
|
what is the treatment of neuroleptic induced akathisia?
|
propanolol
|
|
what is the treatment of neuroleptic induced akathisia?
|
propanolol
|
|
what if a patient refuses to eat or drink what should be done?
|
ECT
|
|
what if a patient refuses to eat or drink what should be done?
|
ECT
|
|
what anesthetic is used prior to ECT
|
Methohexital b/c it has a lower cardia risk profile than other barbituates. Used IV, it produces rapid unconciusness and patietns reawaken quickly thereafter, since the duration of action is only 5 to 7 minutes
|
|
what anesthetic is used prior to ECT
|
Methohexital b/c it has a lower cardia risk profile than other barbituates. Used IV, it produces rapid unconciusness and patietns reawaken quickly thereafter, since the duration of action is only 5 to 7 minutes
|
|
flumazenail may cause seizures if
|
someone has a preexisting seizure disorder
|
|
flumazenail may cause seizures if
|
someone has a preexisting seizure disorder
|
|
flumazenail may cause seizures if
|
someone has a preexisting seizure disorder
|
|
Imipramine and amitriptyline
are the prototypical drugs of the class as |
mixed norepinephrine and serotonin uptake inhibitors
though they also have several other properties. |
|
Imipramine and amitriptyline
are the prototypical drugs of the class as |
mixed norepinephrine and serotonin uptake inhibitors
though they also have several other properties. |
|
Patients with depression typically have the following changes in their sleep stages:
|
" decresed slow-wave sleep and REM latency increased total REM sleep and increased REM early in the sleep cycle
|
|
Patients with depression typically have the following changes in their sleep stages:
|
" decresed slow-wave sleep and REM latency increased total REM sleep and increased REM early in the sleep cycle
|
|
Patients with depression typically have the following changes in their sleep stages:
|
" decresed slow-wave sleep and REM latency increased total REM sleep and increased REM early in the sleep cycle
|
|
Stimulates 5-HT1A receptors
|
Buspirone
|
|
Stimulates 5-HT1A receptors
|
Buspirone
|
|
Mirtazapine works by
|
!2 antagonist (" release of NE and serotonin) and
potent 5-HT2 and 5-HT3 receptor antagonist. Toxicity: sedation, " appetite, weight gain, dry mouth. |
|
Mirtazapine works by
|
!2 antagonist (" release of NE and serotonin) and
potent 5-HT2 and 5-HT3 receptor antagonist. Toxicity: sedation, " appetite, weight gain, dry mouth. |
|
Trazodone moa
|
Primarily inhibit serotonin reuptake. Toxicity:
sedation, nausea, priapism, postural hypotension. |
|
Trazodone moa
|
Primarily inhibit serotonin reuptake. Toxicity:
sedation, nausea, priapism, postural hypotension. |
|
Primarily inhibit serotonin reuptake. Toxicity:
sedation, nausea, priapism, postural hypotension. |
Trazodone moa
|
|
name the MAOis
|
Phenelzine, tranylcypromine.
|
|
name the MAOis
|
Phenelzine, tranylcypromine.
|
|
name the MAOis
|
Phenelzine, tranylcypromine.
|
|
Nonselective MAO inhibition # " levels of amine neurotransmitters.
Clinical use? |
Atypical depression (i.e., with mood reactivity, sensitivity to rejection, hypersomnia),
anxiety, hypochondriasis. |
|
Nonselective MAO inhibition # " levels of amine neurotransmitters.
Clinical use? |
Atypical depression (i.e., with mood reactivity, sensitivity to rejection, hypersomnia),
anxiety, hypochondriasis. |
|
MAOI toxicity
|
Hypertensive crisis with tyramine ingestion (in many foods) and $-agonists; CNS
stimulation. Contraindication with SSRIs or meperidine (to prevent serotonin syndrome). |
|
MAOI toxicity
|
Hypertensive crisis with tyramine ingestion (in many foods) and $-agonists; CNS
stimulation. Contraindication with SSRIs or meperidine (to prevent serotonin syndrome). |
|
MAOI toxicity
|
Hypertensive crisis with tyramine ingestion (in many foods) and $-agonists; CNS
stimulation. Contraindication with SSRIs or meperidine (to prevent serotonin syndrome). |
|
MAOI toxicity
|
Hypertensive crisis with tyramine ingestion (in many foods) and $-agonists; CNS
stimulation. Contraindication with SSRIs or meperidine (to prevent serotonin syndrome). |
|
what are the contraindications of MAOIs
|
Contraindication with SSRIs or meperidine (to prevent serotonin syndrome).
|
|
what are the contraindications of MAOIs
|
Contraindication with SSRIs or meperidine (to prevent serotonin syndrome).
|
|
what are the contraindications of MAOIs
|
Contraindication with SSRIs or meperidine (to prevent serotonin syndrome).
|
|
what are the contraindications of MAOIs
|
Contraindication with SSRIs or meperidine (to prevent serotonin syndrome).
|
|
treatment of choice for status
|
diazepam
|
|
treatment of choice for status
|
diazepam
|
|
treatment of choice for status
|
diazepam
|
|
treatment of choice for status
|
diazepam
|